{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:02:36Z","timestamp":1774638156494,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023TG012"],"award-info":[{"award-number":["2023TG012"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Fundation of Fujian Province","award":["2022J01218"],"award-info":[{"award-number":["2022J01218"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01791-3","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:19:03Z","timestamp":1760519943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a recurrence-related gene signature and functional role of MLLT6 in ovarian cancer progression and Paclitaxel resistance"],"prefix":"10.1186","volume":"18","author":[{"given":"Qiufang","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linliang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"crossref","unstructured":"Zhan S, Yung MMH, Siu MKY, Jiao P, Ngan HYS, Chan DW. K. K. L. Chan. New insights into ferroptosis initiating therapies (FIT) by targeting the rewired lipid metabolism in ovarian cancer peritoneal metastases. Int J Mol Sci. 2022; 23.","DOI":"10.3390\/ijms232315263"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","volume":"137","author":"KC Kurnit","year":"2021","unstructured":"Kurnit KC, Fleming GF. Lengyel. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol. 2021;137:108\u201321.","journal-title":"Obstet Gynecol"},{"key":"1791_CR3","doi-asserted-by":"crossref","unstructured":"Cammarata G, Barraco N, Giusti I, Gristina V, Dolo V. S. Taverna. Extracellular Vesicles-ceRNAs as ovarian cancer biomarkers: looking into circRNA-miRNA-mRNA code. Cancers (Basel). 2022; 14.","DOI":"10.3390\/cancers14143404"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1756-9966-30-91","volume":"30","author":"N Eckstein","year":"2011","unstructured":"Eckstein N. Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res. 2011;30:91.","journal-title":"J Exp Clin Cancer Res"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I. Oza. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353.","journal-title":"Lancet"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJMc1616633","volume":"376","author":"MR Mirza","year":"2017","unstructured":"Mirza MR. Matulonis. Niraparib in recurrent ovarian cancer. N Engl J Med. 2017;376:801\u20132.","journal-title":"N Engl J Med"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.annonc.2021.02.015","volume":"32","author":"T Baert","year":"2021","unstructured":"Baert T, Ferrero A, Sehouli J, O\u2019donnell DM, Gonz\u00e1lez-Mart\u00edn A, Joly F, Van Der Velden J, Blecharz P, Tan DSP, Querleu D, Colombo N, Du Bois A. Ledermann. The systemic treatment of recurrent ovarian cancer revisited. Ann Oncol. 2021;32:710\u201325.","journal-title":"Ann Oncol"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1016\/S1470-2045(21)00181-9","volume":"22","author":"PK Garg","year":"2021","unstructured":"Garg PK, Kumar R, Choudhary D. Secondary cytoreduction for relapsed ovarian cancer. Lancet Oncol. 2021;22:e230.","journal-title":"Lancet Oncol"},{"key":"1791_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3399","volume":"12","author":"NJ Curtin","year":"2012","unstructured":"Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12:801\u201317.","journal-title":"Nat Rev Cancer"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","volume":"86","author":"E Schoutrop","year":"2022","unstructured":"Schoutrop E, Moyano-Galceran L, Lheureux S, Mattsson J, Lehti K, Dahlstrand H. Magalhaes. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Semin Cancer Biol. 2022;86:207\u201323.","journal-title":"Semin Cancer Biol"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13073-015-0241-4","volume":"7","author":"E Becht","year":"2015","unstructured":"Becht E, De Reyni\u00e8s A. Fridman. Integrating tumor microenvironment with cancer molecular classifications. Genome Med. 2015;7:115.","journal-title":"Genome Med"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc3485","volume":"13","author":"A D\u2019ambrogio","year":"2013","unstructured":"D\u2019ambrogio A, Nagaoka K, Richter JD. Translational control of cell growth and malignancy by the CPEBs. Nat Rev Cancer. 2013;13:283\u201390.","journal-title":"Nat Rev Cancer"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG. Deberardinis. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657\u201369.","journal-title":"Cell"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43:869\u201374.","journal-title":"Nat Genet"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s43018-022-00361-6","volume":"3","author":"F Na","year":"2022","unstructured":"Na F, Pan X, Chen J, Chen X, Wang M, Chi P, You L, Zhang L, Zhong A, Zhao L, Dai S, Zhang M, Wang Y, et al. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming. Nat Cancer. 2022;3:753\u201367.","journal-title":"Nat Cancer"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"106085","DOI":"10.1016\/j.nbd.2023.106085","volume":"180","author":"DM Romero","year":"2023","unstructured":"Romero DM, Zaidi D, Cifuentes-Diaz C, Maillard C, Grannec G, Selloum M, Birling MC, Bahi-Buisson N. Francis. A human dynein heavy chain mutation impacts cortical progenitor cells causing developmental defects, reduced brain size and altered brain architecture. Neurobiol Dis. 2023;180:106085.","journal-title":"Neurobiol Dis"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.21873\/anticanres.16857","volume":"44","author":"T Oshima","year":"2024","unstructured":"Oshima T, Hashimoto I, Hiroshima Y, Kimura Y, Tanabe M, Onuma S, Morita J, Nagasawa S, Kanematsu K, Aoyama T, Yamada T, Ogata T, Rino Y, et al. Clinical significance of Tryptophanyl-tRNA synthetase 1 gene expression in patients with locally advanced gastric cancer. Anticancer Res. 2024;44:673\u20138.","journal-title":"Anticancer Res"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","volume":"603","author":"A Pataskar","year":"2022","unstructured":"Pataskar A, Champagne J, Nagel R, Kenski J, Laos M, Michaux J, Pak HS, Bleijerveld OB, Mordente K, Navarro JM, Blommaert N, Nielsen MM, Lovecchio D, et al. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature. 2022;603:721\u20137.","journal-title":"Nature"},{"key":"1791_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4048\/jbc.2020.23.e67","volume":"23","author":"KM Lee","year":"2020","unstructured":"Lee KM, Hwang EH, Kang SE, Lee CH, Lee H, Oh HJ, Kim K, Koh J. Ryu. Tryptophanyl-tRNA synthetase sensitizes hormone Receptor-Positive breast cancer to Docetaxel-Based chemotherapy. J Breast Cancer. 2020;23:599\u2013609.","journal-title":"J Breast Cancer"},{"key":"1791_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pathol.2024.09.009","volume":"57","author":"TQ Ngo","year":"2025","unstructured":"Ngo TQ, Goh AFN, Dorwal P, Leong E, Shortt J, Fedele PL, Gilbertson M, Fong CY, Shanmuganathan N, Kumar B. Yeh. Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies. Pathology. 2025;57:340\u20137.","journal-title":"Pathology"},{"key":"1791_CR21","doi-asserted-by":"publisher","first-page":"e50155","DOI":"10.15252\/embr.202050155","volume":"21","author":"S Sreevalsan","year":"2020","unstructured":"Sreevalsan S, D\u00f6ring M, Paszkowski-Rogacz M, Brux M, Blanck C, Meyer M, Momburg F, Buchholz F. Theis. MLLT6 maintains PD-L1 expression and mediates tumor immune resistance. EMBO Rep. 2020;21:e50155.","journal-title":"EMBO Rep"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/1541-7786.MCR-23-0648","volume":"22","author":"Q Yu","year":"2024","unstructured":"Yu Q, Zhao J, Yang A, Li X. MLLT6\/ATF2 axis restrains breast cancer progression by driving DDIT3\/4 expression. Mol Cancer Res. 2024;22:796\u2013811.","journal-title":"Mol Cancer Res"},{"key":"1791_CR23","first-page":"6345","volume":"61","author":"YM Lin","year":"2001","unstructured":"Lin YM, Ono K, Satoh S, Ishiguro H, Fujita M, Miwa N, Tanaka T, Tsunoda T, Yang KC, Nakamura Y. Furukawa. Identification of AF17 as a downstream gene of the beta-catenin\/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res. 2001;61:6345\u20139.","journal-title":"Cancer Res"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/a-2548-1568","volume":"57","author":"H Zhang","year":"2025","unstructured":"Zhang H, Fan MD, Hu Y, Yang Q, Jiang JW, Xu M. Prognostic assessment and analysis of underlying biological mechanisms of prostate cancer based on Estrogen-Related genes. Horm Metab Res. 2025;57:273\u201385.","journal-title":"Horm Metab Res"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13205-024-04161-w","volume":"15","author":"J Tang","year":"2025","unstructured":"Tang J, Liu Z, Xie G, Wang C, Jiang Y. POU4F1 enhances lung cancer gemcitabine resistance by regulating METTL3-dependent TWF1 mRNA N6 adenosine methylation. 3 Biotech. 2025;15:7.","journal-title":"3 Biotech"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2020.09.003","volume":"533","author":"D Wu","year":"2020","unstructured":"Wu D, Jia HY, Wei N, Li SJ. POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1\/2 signaling pathway. Biochem Biophys Res Commun. 2020;533:533\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1791_CR27","doi-asserted-by":"crossref","unstructured":"Jung SN, Kang YE, Lee GH, Liu L, Oh C, Jin YL, Lim MA, Lee K, Oh T, Won HR, Chang JW. B. S. Koo. Brn3a\/Pou4f1 functions as a tumor suppressor by targeting c-MET\/STAT3 signaling in thyroid cancer. J Clin Endocrinol Metab. 2020; 105.","DOI":"10.1210\/clinem\/dgaa316"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"e2411285","DOI":"10.1002\/advs.202411285","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Tan X, Wang L, Ji D, Zhang C, Peng W, Zhu R, Wang X, Zhou J, Feng Y, Sun Y. TRIM38 suppresses the progression of colorectal cancer via enhancing CCT6A ubiquitination to inhibit the MYC pathway. Adv Sci (Weinh). 2025;12:e2411285.","journal-title":"Adv Sci (Weinh)"},{"key":"1791_CR29","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s11010-023-04823-y","volume":"479","author":"K Zhang","year":"2024","unstructured":"Zhang K, Lin G, Nie Z, Jin S, Bing X, Li Z, Li M. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK\/NF-\u03baB\/NLRP3 pathway. Mol Cell Biochem. 2024;479:2069\u201379.","journal-title":"Mol Cell Biochem"},{"key":"1791_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12967-021-03173-x","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, He H, Rui W, Zhang N, Zhu Y, Xie X. TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer. J Transl Med. 2021;19:508.","journal-title":"J Transl Med"},{"key":"1791_CR31","doi-asserted-by":"publisher","first-page":"848476","DOI":"10.3389\/fgene.2022.848476","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhou H, Li S. BTN3A2 expression is connected with favorable prognosis and high infiltrating immune in lung adenocarcinoma. Front Genet. 2022;13:848476.","journal-title":"Front Genet"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1053\/j.gastro.2017.02.017","volume":"152","author":"M Zhu","year":"2017","unstructured":"Zhu M, Yan C, Ren C, Huang X, Zhu X, Gu H, Wang M, Wang S, Gao Y, Ji Y, Miao X, Yang M, Chen J, et al. Exome array analysis identifies variants in SPOCD1 and BTN3A2 that affect risk for gastric cancer. Gastroenterology. 2017;152:2011\u201321.","journal-title":"Gastroenterology"},{"key":"1791_CR33","first-page":"102003","volume":"42","author":"R Raut","year":"2025","unstructured":"Raut R, Srivastava D, Nayak V, Saini T, Gupta P, Chakraborty AK, Choudhury C, Bais MV, Mishra P, Misra A. Clinical data investigation identifies MARK3 as an oncogenic driver in castration-resistant prostate cancer. Biochem Biophys Rep. 2025;42:102003.","journal-title":"Biochem Biophys Rep"},{"key":"1791_CR34","doi-asserted-by":"crossref","unstructured":"Wang Y, Guo L. Mark3 a prognostic marker for the endometrial cancer. Curr Oncol. 2025; 32.","DOI":"10.3390\/curroncol32030157"},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1158\/2159-8290.CD-23-1529","volume":"14","author":"O Klingbeil","year":"2024","unstructured":"Klingbeil O, Skopelitis D, Tonelli C, Yoshimoto T, Alpsoy A, Panepinto MC, Minicozzi F, Merrill JR, Cafiero AM, Aggarwal D, Russo S, Ha T, Demerdash OE, et al. MARK2\/MARK3 kinases are catalytic codependencies of YAP\/TAZ in human cancer. Cancer Discov. 2024;14:2471\u201388.","journal-title":"Cancer Discov"},{"key":"1791_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10142-023-01193-y","volume":"23","author":"C Zhang","year":"2023","unstructured":"Zhang C, Chen S, Wang W, Gao Y. YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR. Funct Integr Genomics. 2023;23:269.","journal-title":"Funct Integr Genomics"},{"key":"1791_CR37","doi-asserted-by":"crossref","unstructured":"Dillen A, Bui I, Jung M, Agioti S, Zaravinos A, Bonavida B. Regulation of PD-L1 expression by YY1 in cancer: therapeutic efficacy of targeting YY1. Cancers (Basel). 2024; 16.","DOI":"10.3390\/cancers16061237"},{"key":"1791_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s12967-025-06555-7","volume":"23","author":"X Ma","year":"2025","unstructured":"Ma X, He Y, Yang Y, Lu T, Tang Z, Cui Y, Wang R. YY1-induced DDX18 modulates EMT via the akt\/mtor pathway in esophageal cancer: a novel therapeutic target. J Transl Med. 2025;23:562.","journal-title":"J Transl Med"},{"key":"1791_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s42003-025-08101-z","volume":"8","author":"C Wu","year":"2025","unstructured":"Wu C, Long L, Wang M, Shen L, Hu J, Tang H, Feng S, Liu X, Shi Y, Tang S. Chen. Copper-mediated SEC14L3 promotes Cuproptosis to inhibit hepatocellular carcinoma growth via ERK\/YY1\/FDX1 axis. Commun Biol. 2025;8:658.","journal-title":"Commun Biol"},{"key":"1791_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","volume":"121","author":"A Leonetti","year":"2019","unstructured":"Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E. Tiseo. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer. 2019;121:725\u201337.","journal-title":"Br J Cancer"},{"key":"1791_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1042\/CS20201412","volume":"135","author":"KB Neves","year":"2021","unstructured":"Neves KB, Morris HE, Alves-Lopes R, Muir KW, Moreton F, Delles C, Montezano AC. Touyz. Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of no\/sgc\/cgmp pathway. Clin Sci (Lond). 2021;135:753\u201373.","journal-title":"Clin Sci (Lond)"},{"key":"1791_CR42","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, Wilhelm J, Li S, Song J, Li W, Sun Z, Sumer BD, Li B, et al. Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity. Nat Commun. 2022;13:4981.","journal-title":"Nat Commun"},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, Sun Y, Hu Y, Wu B, Wu G, Lovell JF, Jin H, Yang K. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated macrophages in lung cancer. Theranostics. 2020;10:9332\u201347.","journal-title":"Theranostics"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01791-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01791-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:19:07Z","timestamp":1760519947000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01791-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01791-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"224"}}